Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Engineering a vascularized-osteogenic microenvironment to enhance bone regeneration via a 3D-printed composite scaffold with progressive-release bio-factors

Shao T., Hu G., Bai Y., Li Y., Xiao H., Han Y.

Animal Study on Face & Skin, published in J Transl Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Transl Med (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41963944
PMCID
PMC13088540
DOI
10.1186/s12967-026-08090-5
Citations
1

Abstract (original English)

BACKGROUND: Critical-sized bone defects remain challenging to repair because successful regeneration requires both mechanical stability and the coordinated promotion of osteogenesis and vascularization. To address these needs, we developed a composite scaffold (GV@PHL) that integrates structural support with sustained pro-angiogenic signaling. METHODS: A 3D-printed framework composed of polycaprolactone (PCL), nano-hydroxyapatite (nano-HA), and Laponite (PHL) was fabricated to form an interconnected porous architecture with intrinsic osteogenic potential and printability. A GelMA hydrogel was photo-crosslinked within the scaffold pores and covalently tethered to vascular endothelial growth factor (VEGF) to create a photo-embedded GelMA–VEGF phase, enabling sustained VEGF release. The composite scaffold (GV@PHL) was evaluated through in vitro and in vivo experiments to assess architecture stability, osteogenic differentiation, VEGF release behavior, endothelial cell responses, and vascularization. RESULTS: The GV@PHL scaffold maintained a stable porous architecture and exhibited synergistic performance combining structural integrity with biological activity. The PHL framework supported osteogenic differentiation, while the photo-crosslinked GelMA–VEGF hydrogel enabled controlled, sustained release of VEGF. Released VEGF promoted endothelial cell survival and enhanced vasculariza

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansDurapatiteSilicatesPolyestersVascular Endothelial Growth Factor AHydrogelsTissue EngineeringBone RegenerationCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research